Sangamo Therapeutics to Present at the Jefferies Cell & Genetic Medicine Summit
September 20 2023 - 4:15PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines
company, today announced that it will participate in the Jefferies
Cell & Genetic Medicine Summit, to be held from September
26-27, 2023 in New York City.
Sandy Macrae, Sangamo’s President and Chief Executive Officer is
scheduled to present on Wednesday, September 27th at 11:00AM ET. A
live webcast of the presentation will be available here and on the
Company’s Investor Events webpage. A replay of the presentation
will be available on the Sangamo Therapeutics website for 90 days
after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is a clinical-stage biopharmaceutical
company with a robust genomic medicines pipeline. Using
ground-breaking science, including our proprietary zinc finger
genome engineering technology and manufacturing expertise, Sangamo
aims to create new genomic medicines for patients suffering from
diseases for which existing treatment options are inadequate or
currently don’t exist. To learn more, visit www.sangamo.com and
connect with us on LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230920374990/en/
Investor Relations & Media
Inquiries Louise Wilkie ir@sangamo.com media@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Apr 2023 to Apr 2024